TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Companion Cancer Diagnostics Market Insights, Forecast to 2028

Global Companion Cancer Diagnostics Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 02 September 2022
  • Pages :96
  • Formats:
  • Report Code:SMR-7318477
OfferClick for best price

Best Price: $3920

Companion Cancer Diagnostics Market Size, Share 2022


Market Analysis and Insights: Global Companion Cancer Diagnostics Market

The global Companion Cancer Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Companion Cancer Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Companion Cancer Diagnostics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Companion Cancer Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Companion Cancer Diagnostics market.

Global Companion Cancer Diagnostics Scope and Market Size

Companion Cancer Diagnostics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Companion Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Breast Cancer

Lung Cancer

Colorectal Cancer

Melanoma

Gastric Cancer

Segment by Application

Pharmaceutical & Biopharmaceutical Companies

Reference Laboratories

CROs

Others

By Company

F. Hoffmann-La Roche

Agilent Technologies

QIAGEN

Abbott Laboratories

Almac Group

Danaher Corporation

bioM?rieuxSA

Myriad Genetics

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Companion Cancer Diagnostics product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Companion Cancer Diagnostics, with price, sales, revenue, and global market share of Companion Cancer Diagnostics from 2019 to 2022.

Chapter 3, the Companion Cancer Diagnostics competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Companion Cancer Diagnostics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Companion Cancer Diagnostics market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Companion Cancer Diagnostics.

Chapter 13, 14, and 15, to describe Companion Cancer Diagnostics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Companion Cancer Diagnostics Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Companion Cancer Diagnostics Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 96 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Companion Cancer Diagnostics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Breast Cancer
1.2.3 Lung Cancer
1.2.4 Colorectal Cancer
1.2.5 Melanoma
1.2.6 Gastric Cancer
1.3 Market by Application
1.3.1 Global Companion Cancer Diagnostics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical & Biopharmaceutical Companies
1.3.3 Reference Laboratories
1.3.4 CROs
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Companion Cancer Diagnostics Market Perspective (2017-2028)
2.2 Companion Cancer Diagnostics Growth Trends by Region
2.2.1 Companion Cancer Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Companion Cancer Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Companion Cancer Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Companion Cancer Diagnostics Market Dynamics
2.3.1 Companion Cancer Diagnostics Industry Trends
2.3.2 Companion Cancer Diagnostics Market Drivers
2.3.3 Companion Cancer Diagnostics Market Challenges
2.3.4 Companion Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Companion Cancer Diagnostics Players by Revenue
3.1.1 Global Top Companion Cancer Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Companion Cancer Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Companion Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Companion Cancer Diagnostics Revenue
3.4 Global Companion Cancer Diagnostics Market Concentration Ratio
3.4.1 Global Companion Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Companion Cancer Diagnostics Revenue in 2021
3.5 Companion Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players Companion Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into Companion Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Companion Cancer Diagnostics Breakdown Data by Type
4.1 Global Companion Cancer Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Companion Cancer Diagnostics Forecasted Market Size by Type (2023-2028)
5 Companion Cancer Diagnostics Breakdown Data by Application
5.1 Global Companion Cancer Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Companion Cancer Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Companion Cancer Diagnostics Market Size (2017-2028)
6.2 North America Companion Cancer Diagnostics Market Size by Type
6.2.1 North America Companion Cancer Diagnostics Market Size by Type (2017-2022)
6.2.2 North America Companion Cancer Diagnostics Market Size by Type (2023-2028)
6.2.3 North America Companion Cancer Diagnostics Market Share by Type (2017-2028)
6.3 North America Companion Cancer Diagnostics Market Size by Application
6.3.1 North America Companion Cancer Diagnostics Market Size by Application (2017-2022)
6.3.2 North America Companion Cancer Diagnostics Market Size by Application (2023-2028)
6.3.3 North America Companion Cancer Diagnostics Market Share by Application (2017-2028)
6.4 North America Companion Cancer Diagnostics Market Size by Country
6.4.1 North America Companion Cancer Diagnostics Market Size by Country (2017-2022)
6.4.2 North America Companion Cancer Diagnostics Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Companion Cancer Diagnostics Market Size (2017-2028)
7.2 Europe Companion Cancer Diagnostics Market Size by Type
7.2.1 Europe Companion Cancer Diagnostics Market Size by Type (2017-2022)
7.2.2 Europe Companion Cancer Diagnostics Market Size by Type (2023-2028)
7.2.3 Europe Companion Cancer Diagnostics Market Share by Type (2017-2028)
7.3 Europe Companion Cancer Diagnostics Market Size by Application
7.3.1 Europe Companion Cancer Diagnostics Market Size by Application (2017-2022)
7.3.2 Europe Companion Cancer Diagnostics Market Size by Application (2023-2028)
7.3.3 Europe Companion Cancer Diagnostics Market Share by Application (2017-2028)
7.4 Europe Companion Cancer Diagnostics Market Size by Country
7.4.1 Europe Companion Cancer Diagnostics Market Size by Country (2017-2022)
7.4.2 Europe Companion Cancer Diagnostics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Companion Cancer Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Companion Cancer Diagnostics Market Size by Type
8.2.1 Asia-Pacific Companion Cancer Diagnostics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Companion Cancer Diagnostics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Companion Cancer Diagnostics Market Share by Type (2017-2028)
8.3 Asia-Pacific Companion Cancer Diagnostics Market Size by Application
8.3.1 Asia-Pacific Companion Cancer Diagnostics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Companion Cancer Diagnostics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Companion Cancer Diagnostics Market Share by Application (2017-2028)
8.4 Asia-Pacific Companion Cancer Diagnostics Market Size by Region
8.4.1 Asia-Pacific Companion Cancer Diagnostics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Companion Cancer Diagnostics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Companion Cancer Diagnostics Market Size (2017-2028)
9.2 Latin America Companion Cancer Diagnostics Market Size by Type
9.2.1 Latin America Companion Cancer Diagnostics Market Size by Type (2017-2022)
9.2.2 Latin America Companion Cancer Diagnostics Market Size by Type (2023-2028)
9.2.3 Latin America Companion Cancer Diagnostics Market Share by Type (2017-2028)
9.3 Latin America Companion Cancer Diagnostics Market Size by Application
9.3.1 Latin America Companion Cancer Diagnostics Market Size by Application (2017-2022)
9.3.2 Latin America Companion Cancer Diagnostics Market Size by Application (2023-2028)
9.3.3 Latin America Companion Cancer Diagnostics Market Share by Application (2017-2028)
9.4 Latin America Companion Cancer Diagnostics Market Size by Country
9.4.1 Latin America Companion Cancer Diagnostics Market Size by Country (2017-2022)
9.4.2 Latin America Companion Cancer Diagnostics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Companion Cancer Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Companion Cancer Diagnostics Market Size by Type
10.2.1 Middle East & Africa Companion Cancer Diagnostics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Companion Cancer Diagnostics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Companion Cancer Diagnostics Market Share by Type (2017-2028)
10.3 Middle East & Africa Companion Cancer Diagnostics Market Size by Application
10.3.1 Middle East & Africa Companion Cancer Diagnostics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Companion Cancer Diagnostics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Companion Cancer Diagnostics Market Share by Application (2017-2028)
10.4 Middle East & Africa Companion Cancer Diagnostics Market Size by Country
10.4.1 Middle East & Africa Companion Cancer Diagnostics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Companion Cancer Diagnostics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Details
11.1.2 F. Hoffmann-La Roche Business Overview
11.1.3 F. Hoffmann-La Roche Companion Cancer Diagnostics Introduction
11.1.4 F. Hoffmann-La Roche Revenue in Companion Cancer Diagnostics Business (2017-2022)
11.1.5 F. Hoffmann-La Roche Recent Developments
11.2 Agilent Technologies
11.2.1 Agilent Technologies Company Details
11.2.2 Agilent Technologies Business Overview
11.2.3 Agilent Technologies Companion Cancer Diagnostics Introduction
11.2.4 Agilent Technologies Revenue in Companion Cancer Diagnostics Business (2017-2022)
11.2.5 Agilent Technologies Recent Developments
11.3 QIAGEN
11.3.1 QIAGEN Company Details
11.3.2 QIAGEN Business Overview
11.3.3 QIAGEN Companion Cancer Diagnostics Introduction
11.3.4 QIAGEN Revenue in Companion Cancer Diagnostics Business (2017-2022)
11.3.5 QIAGEN Recent Developments
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Companion Cancer Diagnostics Introduction
11.4.4 Abbott Laboratories Revenue in Companion Cancer Diagnostics Business (2017-2022)
11.4.5 Abbott Laboratories Recent Developments
11.5 Almac Group
11.5.1 Almac Group Company Details
11.5.2 Almac Group Business Overview
11.5.3 Almac Group Companion Cancer Diagnostics Introduction
11.5.4 Almac Group Revenue in Companion Cancer Diagnostics Business (2017-2022)
11.5.5 Almac Group Recent Developments
11.6 Danaher Corporation
11.6.1 Danaher Corporation Company Details
11.6.2 Danaher Corporation Business Overview
11.6.3 Danaher Corporation Companion Cancer Diagnostics Introduction
11.6.4 Danaher Corporation Revenue in Companion Cancer Diagnostics Business (2017-2022)
11.6.5 Danaher Corporation Recent Developments
11.7 bioM?rieuxSA
11.7.1 bioM?rieuxSA Company Details
11.7.2 bioM?rieuxSA Business Overview
11.7.3 bioM?rieuxSA Companion Cancer Diagnostics Introduction
11.7.4 bioM?rieuxSA Revenue in Companion Cancer Diagnostics Business (2017-2022)
11.7.5 bioM?rieuxSA Recent Developments
11.8 Myriad Genetics
11.8.1 Myriad Genetics Company Details
11.8.2 Myriad Genetics Business Overview
11.8.3 Myriad Genetics Companion Cancer Diagnostics Introduction
11.8.4 Myriad Genetics Revenue in Companion Cancer Diagnostics Business (2017-2022)
11.8.5 Myriad Genetics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Companion Cancer Diagnostics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Breast Cancer
Table 3. Key Players of Lung Cancer
Table 4. Key Players of Colorectal Cancer
Table 5. Key Players of Melanoma
Table 6. Key Players of Gastric Cancer
Table 7. Global Companion Cancer Diagnostics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 8. Global Companion Cancer Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Companion Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 10. Global Companion Cancer Diagnostics Market Share by Region (2017-2022)
Table 11. Global Companion Cancer Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 12. Global Companion Cancer Diagnostics Market Share by Region (2023-2028)
Table 13. Companion Cancer Diagnostics Market Trends
Table 14. Companion Cancer Diagnostics Market Drivers
Table 15. Companion Cancer Diagnostics Market Challenges
Table 16. Companion Cancer Diagnostics Market Restraints
Table 17. Global Companion Cancer Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 18. Global Companion Cancer Diagnostics Revenue Share by Players (2017-2022)
Table 19. Global Top Companion Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Cancer Diagnostics as of 2021)
Table 20. Ranking of Global Top Companion Cancer Diagnostics Companies by Revenue (US$ Million) in 2021
Table 21. Global 5 Largest Players Market Share by Companion Cancer Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Companion Cancer Diagnostics Product Solution and Service
Table 24. Date of Enter into Companion Cancer Diagnostics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Companion Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 27. Global Companion Cancer Diagnostics Revenue Market Share by Type (2017-2022)
Table 28. Global Companion Cancer Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 29. Global Companion Cancer Diagnostics Revenue Market Share by Type (2023-2028)
Table 30. Global Companion Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 31. Global Companion Cancer Diagnostics Revenue Share by Application (2017-2022)
Table 32. Global Companion Cancer Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 33. Global Companion Cancer Diagnostics Revenue Share by Application (2023-2028)
Table 34. North America Companion Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 35. North America Companion Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 36. North America Companion Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 37. North America Companion Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 38. North America Companion Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 39. North America Companion Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 40. Europe Companion Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 41. Europe Companion Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 42. Europe Companion Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 43. Europe Companion Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 44. Europe Companion Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 45. Europe Companion Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 46. Asia Pacific Companion Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 47. Asia Pacific Companion Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 48. Asia Pacific Companion Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 49. Asia Pacific Companion Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 50. Asia Pacific Companion Cancer Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 51. Asia Pacific Companion Cancer Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 52. Latin America Companion Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 53. Latin America Companion Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 54. Latin America Companion Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 55. Latin America Companion Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 56. Latin America Companion Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 57. Latin America Companion Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Companion Cancer Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Companion Cancer Diagnostics Market Size by Type (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Companion Cancer Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Companion Cancer Diagnostics Market Size by Application (2023-2028) & (US$ Million)
Table 62. Middle East and Africa Companion Cancer Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 63. Middle East and Africa Companion Cancer Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 64. F. Hoffmann-La Roche Company Details
Table 65. F. Hoffmann-La Roche Business Overview
Table 66. F. Hoffmann-La Roche Companion Cancer Diagnostics Product
Table 67. F. Hoffmann-La Roche Revenue in Companion Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 68. F. Hoffmann-La Roche Recent Developments
Table 69. Agilent Technologies Company Details
Table 70. Agilent Technologies Business Overview
Table 71. Agilent Technologies Companion Cancer Diagnostics Product
Table 72. Agilent Technologies Revenue in Companion Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 73. Agilent Technologies Recent Developments
Table 74. QIAGEN Company Details
Table 75. QIAGEN Business Overview
Table 76. QIAGEN Companion Cancer Diagnostics Product
Table 77. QIAGEN Revenue in Companion Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 78. QIAGEN Recent Developments
Table 79. Abbott Laboratories Company Details
Table 80. Abbott Laboratories Business Overview
Table 81. Abbott Laboratories Companion Cancer Diagnostics Product
Table 82. Abbott Laboratories Revenue in Companion Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 83. Abbott Laboratories Recent Developments
Table 84. Almac Group Company Details
Table 85. Almac Group Business Overview
Table 86. Almac Group Companion Cancer Diagnostics Product
Table 87. Almac Group Revenue in Companion Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 88. Almac Group Recent Developments
Table 89. Danaher Corporation Company Details
Table 90. Danaher Corporation Business Overview
Table 91. Danaher Corporation Companion Cancer Diagnostics Product
Table 92. Danaher Corporation Revenue in Companion Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 93. Danaher Corporation Recent Developments
Table 94. bioM?rieuxSA Company Details
Table 95. bioM?rieuxSA Business Overview
Table 96. bioM?rieuxSA Companion Cancer Diagnostics Product
Table 97. bioM?rieuxSA Revenue in Companion Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 98. bioM?rieuxSA Recent Developments
Table 99. Myriad Genetics Company Details
Table 100. Myriad Genetics Business Overview
Table 101. Myriad Genetics Companion Cancer Diagnostics Product
Table 102. Myriad Genetics Revenue in Companion Cancer Diagnostics Business (2017-2022) & (US$ Million)
Table 103. Myriad Genetics Recent Developments
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Companion Cancer Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. Breast Cancer Features
Figure 3. Lung Cancer Features
Figure 4. Colorectal Cancer Features
Figure 5. Melanoma Features
Figure 6. Gastric Cancer Features
Figure 7. Global Companion Cancer Diagnostics Market Share by Application: 2021 VS 2028
Figure 8. Pharmaceutical & Biopharmaceutical Companies Case Studies
Figure 9. Reference Laboratories Case Studies
Figure 10. CROs Case Studies
Figure 11. Others Case Studies
Figure 12. Companion Cancer Diagnostics Report Years Considered
Figure 13. Global Companion Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 14. Global Companion Cancer Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Companion Cancer Diagnostics Market Share by Region: 2021 VS 2028
Figure 16. Global Companion Cancer Diagnostics Market Share by Players in 2021
Figure 17. Global Top Companion Cancer Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Companion Cancer Diagnostics as of 2021)
Figure 18. The Top 10 and 5 Players Market Share by Companion Cancer Diagnostics Revenue in 2021
Figure 19. North America Companion Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 20. North America Companion Cancer Diagnostics Market Size Market Share by Type (2017-2028)
Figure 21. North America Companion Cancer Diagnostics Market Size Market Share by Application (2017-2028)
Figure 22. North America Companion Cancer Diagnostics Market Size Share by Country (2017-2028)
Figure 23. United States Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Canada Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Companion Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 26. Europe Companion Cancer Diagnostics Market Size Market Share by Type (2017-2028)
Figure 27. Europe Companion Cancer Diagnostics Market Size Market Share by Application (2017-2028)
Figure 28. Europe Companion Cancer Diagnostics Market Size Share by Country (2017-2028)
Figure 29. Germany Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. France Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. U.K. Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Italy Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Russia Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Nordic Countries Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Asia-Pacific Companion Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 36. Asia Pacific Companion Cancer Diagnostics Market Size Market Share by Type (2017-2028)
Figure 37. Asia Pacific Companion Cancer Diagnostics Market Size Market Share by Application (2017-2028)
Figure 38. Asia Pacific Companion Cancer Diagnostics Market Size Share by Region (2017-2028)
Figure 39. China Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Japan Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. South Korea Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Southeast Asia Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. India Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Australia Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 45. Latin America Companion Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 46. Latin America Companion Cancer Diagnostics Market Size Market Share by Type (2017-2028)
Figure 47. Latin America Companion Cancer Diagnostics Market Size Market Share by Application (2017-2028)
Figure 48. Latin America Companion Cancer Diagnostics Market Size Share by Country (2017-2028)
Figure 49. Mexico Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Brazil Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Companion Cancer Diagnostics Market Size YoY (2017-2028) & (US$ Million)
Figure 52. Middle East and Africa Companion Cancer Diagnostics Market Size Market Share by Type (2017-2028)
Figure 53. Middle East and Africa Companion Cancer Diagnostics Market Size Market Share by Application (2017-2028)
Figure 54. Middle East and Africa Companion Cancer Diagnostics Market Size Share by Country (2017-2028)
Figure 55. Turkey Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Saudi Arabia Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. UAE Companion Cancer Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 58. F. Hoffmann-La Roche Revenue Growth Rate in Companion Cancer Diagnostics Business (2017-2022)
Figure 59. Agilent Technologies Revenue Growth Rate in Companion Cancer Diagnostics Business (2017-2022)
Figure 60. QIAGEN Revenue Growth Rate in Companion Cancer Diagnostics Business (2017-2022)
Figure 61. Abbott Laboratories Revenue Growth Rate in Companion Cancer Diagnostics Business (2017-2022)
Figure 62. Almac Group Revenue Growth Rate in Companion Cancer Diagnostics Business (2017-2022)
Figure 63. Danaher Corporation Revenue Growth Rate in Companion Cancer Diagnostics Business (2017-2022)
Figure 64. bioM?rieuxSA Revenue Growth Rate in Companion Cancer Diagnostics Business (2017-2022)
Figure 65. Myriad Genetics Revenue Growth Rate in Companion Cancer Diagnostics Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount